These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15250512)

  • 1. Dynamics of bacterial carriage and disease: lessons from the meningococcus.
    Maiden MC
    Adv Exp Med Biol; 2004; 549():23-9. PubMed ID: 15250512
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncloaking the meningococcus: dynamics of carriage and disease.
    Stephens DS
    Lancet; 1999 Mar; 353(9157):941-2. PubMed ID: 10459897
    [No Abstract]   [Full Text] [Related]  

  • 3. Rise in Group W Meningococcal Carriage in University Students, United Kingdom.
    Oldfield NJ; Cayrou C; AlJannat MAK; Al-Rubaiawi AAA; Green LR; Dada S; Steels OD; Stirrup C; Wanford J; Atwah BAY; Bayliss CD; Turner DPJ
    Emerg Infect Dis; 2017 Jun; 23(6):1009-1011. PubMed ID: 28518025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 6. Neisseria: recent advances and future challenges.
    Criss AK; Tang C
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28957453
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbiology. A furtive pathogen revealed.
    Nassif X
    Science; 2000 Mar; 287(5459):1767-8. PubMed ID: 10755929
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.
    Jodar L; Cartwright K; Feavers IM
    Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447
    [No Abstract]   [Full Text] [Related]  

  • 9. A vaccine against meningitis in Africa.
    Lancet Infect Dis; 2011 Jan; 11(1):1. PubMed ID: 21183138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Meningococcal meningitis].
    Haruta T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):286-8. PubMed ID: 10088395
    [No Abstract]   [Full Text] [Related]  

  • 11. Defences against meningococcal infections.
    Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
    PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of BC meningococcal vaccine in Brazil.
    Nishioka S
    Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine].
    Del Real G
    Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419
    [No Abstract]   [Full Text] [Related]  

  • 18. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.
    Stephens DS; Greenwood B; Brandtzaeg P
    Lancet; 2007 Jun; 369(9580):2196-2210. PubMed ID: 17604802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.